$ACHV
ACHIEVE LIFE SCIENCES, INC.

2014 Q1 Form 10-K Financial Statement

#000119312514093757 Filed on March 11, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q4 2013
Revenue $11.73M $8.600M $29.88M
YoY Change 130.91% -12.07% 48.66%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.760M $2.450M $9.890M
YoY Change 10.4% 20.1% 26.96%
% of Gross Profit
Research & Development $16.90M $13.20M $55.32M
YoY Change 55.72% -15.66% 38.47%
% of Gross Profit
Depreciation & Amortization $55.00K $70.00K $227.0K
YoY Change 25.0% 133.33% 127.0%
% of Gross Profit
Operating Expenses $16.90M $13.20M $65.21M
YoY Change 55.72% -15.66% 63.23%
Operating Profit
YoY Change
Interest Expense $10.00K $30.00K $150.0K
YoY Change -80.0% -57.14% -48.28%
% of Operating Profit
Other Income/Expense, Net -$707.0K $359.0K $3.478M
YoY Change -144.69% -83.28% -28.86%
Pretax Income -$8.640M -$6.680M -$31.85M
YoY Change 28.96% 62.93% 50.95%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$8.636M -$6.678M -$31.85M
YoY Change 28.95% 62.76% 50.96%
Net Earnings / Revenue -73.62% -77.65% -106.59%
Basic Earnings Per Share
Diluted Earnings Per Share -$864.0M -$668.0M -$3.185B
COMMON SHARES
Basic Shares Outstanding 14.72M shares 14.71M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2013 Q4 2013
SHORT-TERM ASSETS
Cash & Short-Term Investments $37.60M $39.20M $39.22M
YoY Change -41.8% -48.01% -47.97%
Cash & Equivalents $28.63M $14.59M $4.020M
Short-Term Investments $8.900M $24.60M $24.63M
Other Short-Term Assets $1.800M $5.800M $5.770M
YoY Change -47.06% 52.63% 53.46%
Inventory
Prepaid Expenses $5.770M
Receivables $8.610M $8.657M $8.660M
Other Receivables $200.0K $200.0K $220.0K
Total Short-Term Assets $48.15M $53.87M $53.87M
YoY Change -34.49% -32.82% -32.81%
LONG-TERM ASSETS
Property, Plant & Equipment $349.0K $397.0K $400.0K
YoY Change -12.75% 7.01% 8.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.075M $1.111M $1.430M
YoY Change -28.33% -3.56% -2.72%
Total Long-Term Assets $1.675M $1.822M $1.820M
YoY Change -11.84% -0.82% -1.09%
TOTAL ASSETS
Total Short-Term Assets $48.15M $53.87M $53.87M
Total Long-Term Assets $1.675M $1.822M $1.820M
Total Assets $49.82M $55.69M $55.69M
YoY Change -33.92% -32.1% -32.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $923.0K $139.0K $140.0K
YoY Change -88.32% -89.54% -89.47%
Accrued Expenses $13.04M $11.78M $13.49M
YoY Change 181.91% 135.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.100M $1.100M $1.090M
YoY Change 0.0% 0.0% 0.93%
Total Short-Term Liabilities $16.90M $14.93M $14.93M
YoY Change 53.64% 29.23% 29.15%
LONG-TERM LIABILITIES
Long-Term Debt $3.300M $3.500M $3.540M
YoY Change -19.51% -18.6% -16.71%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.300M $3.500M $3.540M
YoY Change -19.51% -18.6% -16.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.90M $14.93M $14.93M
Total Long-Term Liabilities $3.300M $3.500M $3.540M
Total Liabilities $20.22M $18.48M $18.48M
YoY Change 33.91% 16.88% 16.89%
SHAREHOLDERS EQUITY
Retained Earnings -$142.3M -$133.7M
YoY Change 31.27%
Common Stock $169.3M $168.3M
YoY Change 1.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $29.60M $37.21M $37.21M
YoY Change
Total Liabilities & Shareholders Equity $49.82M $55.69M $55.69M
YoY Change -33.92% -32.1% -32.1%

Cashflow Statement

Concept 2014 Q1 2013 Q4 2013
OPERATING ACTIVITIES
Net Income -$8.636M -$6.678M -$31.85M
YoY Change 28.95% 62.76% 50.96%
Depreciation, Depletion And Amortization $55.00K $70.00K $227.0K
YoY Change 25.0% 133.33% 127.0%
Cash From Operating Activities -$1.690M -$7.540M -$35.93M
YoY Change -84.19% -20.55% -17.4%
INVESTING ACTIVITIES
Capital Expenditures $7.000K -$20.00K $253.0K
YoY Change -93.64% -88.89% -13.06%
Acquisitions
YoY Change
Other Investing Activities $15.71M $9.200M $32.68M
YoY Change 38.41% -43.9% -256.36%
Cash From Investing Activities $15.70M $9.180M $32.43M
YoY Change 39.68% -43.44% -253.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 30.00K 0.000 10.00K
YoY Change 200.0% -99.98%
NET CHANGE
Cash From Operating Activities -1.690M -7.540M -35.93M
Cash From Investing Activities 15.70M 9.180M 32.43M
Cash From Financing Activities 30.00K 0.000 10.00K
Net Change In Cash 14.04M 1.640M -3.491M
YoY Change 2407.14% -75.67% -66.57%
FREE CASH FLOW
Cash From Operating Activities -$1.690M -$7.540M -$35.93M
Capital Expenditures $7.000K -$20.00K $253.0K
Free Cash Flow -$1.697M -$7.520M -$36.18M
YoY Change -84.29% -19.23% -17.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4165000 shares
CY2012Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
12.00
CY2012Q1 ogxi Additional Issuance Of Common Stock
AdditionalIssuanceOfCommonStock
624750 shares
CY2012Q1 ogxi Additional Issuance Of Common Stock Per Share
AdditionalIssuanceOfCommonStockPerShare
12.00
CY2012Q1 ogxi Net Amount Received From Public Offering
NetAmountReceivedFromPublicOffering
53800000
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14718610 shares
CY2013Q2 dei Entity Public Float
EntityPublicFloat
143867871
CY2010Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3174602 shares
CY2010Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
15.75
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23533000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.82
CY2010Q4 ogxi Common Stock Shares Issued Description
CommonStockSharesIssuedDescription
Each unit consisting of one share of our common stock and one-half (1/2) of one warrant
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
744913 shares
CY2010Q4 ogxi Net Amount Received From Public Offering
NetAmountReceivedFromPublicOffering
50000000
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.74
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
44125000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
766328 shares
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1936000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
30890000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28517000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14656916 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14656916 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.34
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
804781 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4180000
CY2012Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
1084000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
604000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1329000
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
73609000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11556000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2637000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1967000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1541000
CY2012Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3422000
CY2012Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
4253000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
66207000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
165395000
CY2012Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2012Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0
CY2012Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
3422000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-101840000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
15000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
82016000
CY2012Q4 us-gaap Liabilities
Liabilities
15809000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Assets Current
AssetsCurrent
80179000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2077000
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
314000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1152000
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3755000
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
62489000
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
73609000
CY2012Q4 us-gaap Assets
Assets
82016000
CY2012Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
75697000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18075000
CY2012Q4 us-gaap Short Term Investments
ShortTermInvestments
57308000
CY2012Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
51000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
714000
CY2012Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
930000
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
975000
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6212000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Restructuring Charges
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges
1799000
CY2012Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
141500000
CY2012Q4 us-gaap Cash
Cash
2440000
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
51000
CY2012Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
327000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
371000
CY2012Q4 ogxi Non Capital Loss Carryforwards Amount
NonCapitalLossCarryforwardsAmount
58300000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14707886 shares
CY2013Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1006991 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1587301 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14707886 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.39
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1006991 shares
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
10.95
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
11.39
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
685741 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11784000
CY2013Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
1092000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
814000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
139000
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
84138000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14934000
CY2013Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
300000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2643000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2007000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1705000
CY2013Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
214000
CY2013Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
3544000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
37211000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
168242000
CY2013Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0
CY2013Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
214000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-133689000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
15000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55689000
CY2013Q4 us-gaap Liabilities
Liabilities
18478000
CY2013Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
2000000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
80000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
53867000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2578000
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
314000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1111000
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5770000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
72115000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
84138000
CY2013Q4 us-gaap Assets
Assets
55689000
CY2013Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
39536000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14593000
CY2013Q4 us-gaap Short Term Investments
ShortTermInvestments
24629000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8657000
CY2013Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
951000
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1211000
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6857000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Restructuring Charges
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges
1567000
CY2013Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
150255000
CY2013Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
39200000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1400000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
1400000
CY2013Q4 us-gaap Cash
Cash
10575000
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2700000
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
70000
CY2013Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
218000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
397000
CY2013Q4 ogxi Indemnification Expense
IndemnificationExpense
0
CY2013Q4 ogxi Non Capital Loss Carryforwards Amount
NonCapitalLossCarryforwardsAmount
80934000
CY2010Q4 ogxi Class Of Warrant Or Right Exercise Price Of Warrant Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantOrRights
20
CY2010Q4 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
46700000
CY2010Q4 ogxi Additional Warrant Liability Due To Allocated By Proceeds From Warrant Issued
AdditionalWarrantLiabilityDueToAllocatedByProceedsFromWarrantIssued
15400000
CY2010Q4 ogxi Additional Common Shares Due To Allocated By Proceeds From Warrant Issued
AdditionalCommonSharesDueToAllocatedByProceedsFromWarrantIssued
32300000
CY2010Q4 ogxi Warrant Issuance Expenses
WarrantIssuanceExpenses
1000000
CY2009 us-gaap Licenses Revenue
LicensesRevenue
22000000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0170 pure
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
13.95
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
22986 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.76 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
41.91
CY2011 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
CY2011 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9729340 shares
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
15.72
CY2011 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
0 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.70
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20263000
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.51
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.88
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
101600 shares
CY2011 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
56228 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
971 shares
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2400000 shares
CY2011 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
588000
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1278000
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14642000
CY2011 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1100000
CY2011 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
75147000
CY2011 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
219000
CY2011 us-gaap Investment Income Interest
InvestmentIncomeInterest
220000
CY2011 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
31000
CY2011 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-211000
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-201000
CY2011 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7614000
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-14673000
CY2011 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
31000
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1188000
CY2011 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
-125000
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
79000
CY2011 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
31000
CY2011 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2011 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7388000
CY2011 us-gaap Costs And Expenses
CostsAndExpenses
27783000
CY2011 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
855000
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6230000
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
219000
CY2011 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6175000
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3351000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
600000
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
1188000
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4984000
CY2011 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2600000
CY2011 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
247000
CY2011 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4989000
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
25068000
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21553000
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-2366000
CY2011 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
219000
CY2011 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
87638000
CY2011 us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-407000
CY2011 us-gaap Depreciation
Depreciation
75000
CY2011 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
1326000
CY2011 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
12656000
CY2011 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1222000
CY2011 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2011 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-40000
CY2011 ogxi Number Of Warrants Exercised
NumberOfWarrantsExercised
0 shares
CY2011 ogxi Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
-154000
CY2011 ogxi Income Tax Reconciliation Book To Tax Return Adjustments
IncomeTaxReconciliationBookToTaxReturnAdjustments
-42000
CY2011 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
5496000
CY2011 ogxi Income Tax Reconciliation Reduction In Benefit Of Other Tax Attributes
IncomeTaxReconciliationReductionInBenefitOfOtherTaxAttributes
468000
CY2011 ogxi Property And Equipment Acquired Under Lease Obligation
PropertyAndEquipmentAcquiredUnderLeaseObligation
89000
CY2011 ogxi Future Income Tax Rate Assumed For Deferred Tax Calculations
FutureIncomeTaxRateAssumedForDeferredTaxCalculations
0.34 pure
CY2011 ogxi Income Tax Reconciliation Change In Benefit Of Operating Losses
IncomeTaxReconciliationChangeInBenefitOfOperatingLosses
16000
CY2013 dei Trading Symbol
TradingSymbol
OGXI
CY2013 dei Entity Registrant Name
EntityRegistrantName
ONCOGENEX PHARMACEUTICALS, INC.
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0000949858
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
CY2013 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y2M16D
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0125 pure
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
4.11
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
3061 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.86 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2013 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P5Y
CY2013 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
One-for-eighteen reverse stock split
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
13.87
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14683389 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M18D
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.32
CY2013 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
47495 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.07
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35927000
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.17
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.00
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
239282 shares
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3475 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
30536 shares
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3000000 shares
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3482000
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2800000
CY2013 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
7604000
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10829000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
32426000
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55317000
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-738000
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Use of Estimates</i></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px"><font style="FONT-FAMILY: Times New Roman" size="2">The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and notes thereto. Actual results could differ from these estimates. Estimates and assumptions principally relate to estimates of the fair value of our warrant liability and excess lease facility liability, the initial fair value and forfeiture rates of stock options issued to employees and consultants, the estimated compensation cost on performance restricted stock unit awards and clinical trial and manufacturing accruals.</font></p> </div>
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
8000
CY2013 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
347000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1974000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
32000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31843000
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1800000
CY2013 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
31696000
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
120000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
150000
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6000
CY2013 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-109000
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7943000
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3478000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-31849000
CY2013 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2837000
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
3208000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
253000
CY2013 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
6000
CY2013 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2013 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3208000
CY2013 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
57500000
CY2013 us-gaap Costs And Expenses
CostsAndExpenses
65209000
CY2013 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
164000
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9892000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10000
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
10538000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
34000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
2834000
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10000
CY2013 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
63375000
CY2013 us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-680000
CY2013 us-gaap Depreciation
Depreciation
227000
CY2013 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
2003000
CY2013 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1000000
CY2013 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1190000
CY2013 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-744000
CY2013 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2013 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
9000
CY2013 ogxi Class Of Warrant Or Right Exercise Price Of Warrant Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantOrRights
20
CY2013 ogxi Number Of Warrants Exercised
NumberOfWarrantsExercised
0 shares
CY2013 ogxi Expiration Of Non Cancellable Operating Lease Agreement
ExpirationOfNonCancellableOperatingLeaseAgreement
2017
CY2013 ogxi Maximum Maturity Period Of Short Term Investments
MaximumMaturityPeriodOfShortTermInvestments
P1Y
CY2013 ogxi Collaboration Maximum Additional Payment Received Achievement Of Developmental And Commercial Milestones
CollaborationMaximumAdditionalPaymentReceivedAchievementOfDevelopmentalAndCommercialMilestones
370000000
CY2013 ogxi Percentage Of Likelihood For Recognition Of Uncertain Tax Position
PercentageOfLikelihoodForRecognitionOfUncertainTaxPosition
0.50 pure
CY2013 ogxi Average Period To Maturity For Portfolio Of Cash And Marketable Securities
AveragePeriodToMaturityForPortfolioOfCashAndMarketableSecurities
P50D
CY2013 ogxi Maturity Period Description
MaturityPeriodDescription
One year or less
CY2013 ogxi Maximum Maturity Period Of Cash And Cash Equivalents
MaximumMaturityPeriodOfCashAndCashEquivalents
P90D
CY2013 ogxi Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
21000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2013 ogxi Description Of Maturity Period Of Financial Instruments To Be Considered As Short Term Investment
DescriptionOfMaturityPeriodOfFinancialInstrumentsToBeConsideredAsShortTermInvestment
Greater than three months and less than one year
CY2013 ogxi Income Tax Reconciliation Book To Tax Return Adjustments
IncomeTaxReconciliationBookToTaxReturnAdjustments
127000
CY2013 ogxi Maturity Period Of Highly Liquid Investments To Be Considered As Cash Equivalent
MaturityPeriodOfHighlyLiquidInvestmentsToBeConsideredAsCashEquivalent
P3M
CY2013 ogxi Period Of Not Utilizing Prepaid Amounts Related To Clinical Trials
PeriodOfNotUtilizingPrepaidAmountsRelatedToClinicalTrials
P12M
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43493000
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.56
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.94
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
172650 shares
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
117347 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4541 shares
CY2013 ogxi Maximum Maturity Period Of Collateralized Securities
MaximumMaturityPeriodOfCollateralizedSecurities
P1Y
CY2013 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
29882000
CY2013 ogxi Tax Credit Carryforward Expiration Year Range End
TaxCreditCarryforwardExpirationYearRangeEnd
2033
CY2013 ogxi Number Of Rights Associated With Per Share Of Common Stock
NumberOfRightsAssociatedWithPerShareOfCommonStock
18 Right
CY2013 ogxi Expiration Of Operating Lease Agreement
ExpirationOfOperatingLeaseAgreement
2014-09
CY2013 ogxi Amount To Be Spent In Direct And Indirect Development Costs Under Agreement
AmountToBeSpentInDirectAndIndirectDevelopmentCostsUnderAgreement
30000000
CY2013 ogxi Maximum Maturity Period Of Marketable Securities
MaximumMaturityPeriodOfMarketableSecurities
P1Y
CY2013 ogxi Property And Equipment Acquired Under Lease Obligation
PropertyAndEquipmentAcquiredUnderLeaseObligation
24000
CY2013 ogxi Tax Credit Carryforward Expiration Year Range Start
TaxCreditCarryforwardExpirationYearRangeStart
2014
CY2013 ogxi Unclaimed Tax Deductions Related To Scientific Research And Experimental Development Expenditures
UnclaimedTaxDeductionsRelatedToScientificResearchAndExperimentalDevelopmentExpenditures
13800000
CY2013 ogxi Class Of Warrant Or Right Expiration Year And Month
ClassOfWarrantOrRightExpirationYearAndMonth
2015-10
CY2013 ogxi Future Income Tax Rate Assumed For Deferred Tax Calculations
FutureIncomeTaxRateAssumedForDeferredTaxCalculations
0.34 pure
CY2013 ogxi Class Of Warrant Or Right Expiration Year And Month One
ClassOfWarrantOrRightExpirationYearAndMonthOne
Expiring in October 2015
CY2013 ogxi Shareholder Rights Plan To Acquire Additional Shares Of Common Stock
ShareholderRightsPlanToAcquireAdditionalSharesOfCommonStock
0.15 pure
CY2013 ogxi Income Tax Reconciliation Change In Benefit Of Operating Losses
IncomeTaxReconciliationChangeInBenefitOfOperatingLosses
-10000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0096 pure
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
9.10
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
12309 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.95 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
15.26
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13522723 shares
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.97
CY2012 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
0 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.86
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2600000 shares
CY2012 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
485000
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3037000
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
55000
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21097000
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1600000
CY2012 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
110443000
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
138000
CY2012 us-gaap Nonmonetary Transaction Gain Loss Recognized On Transfer
NonmonetaryTransactionGainLossRecognizedOnTransfer
200000
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
462000
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
292000
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000
CY2012 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
151000
CY2012 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-36000
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
265000
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4889000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-21098000
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2175000
CY2012 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
-63000
CY2012 us-gaap Nonmonetary Transaction Amount Of Barter Transaction
NonmonetaryTransactionAmountOfBarterTransaction
0
CY2012 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
53777000
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
291000
CY2012 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
CY2012 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2012 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4459000
CY2012 us-gaap Costs And Expenses
CostsAndExpenses
46082000
CY2012 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
589000
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7791000
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
54239000
CY2012 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6324000
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-18271000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1200000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
2175000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-10442000
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2700000
CY2012 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3419000
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
53777000
CY2012 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7152000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21188000
CY2012 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
24000
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39948000
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1582000
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-1212000
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
462000
CY2012 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
82181000
CY2012 us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-795000
CY2012 us-gaap Depreciation
Depreciation
100000
CY2012 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
30000000
CY2012 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
1672000
CY2012 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
7365000
CY2012 us-gaap Restructuring Costs
RestructuringCosts
-1657000
CY2012 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-175000
CY2012 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2012 ogxi Number Of Warrants Exercised
NumberOfWarrantsExercised
0 shares
CY2012 ogxi Maximum Maturity Period Of Short Term Investments
MaximumMaturityPeriodOfShortTermInvestments
P1Y
CY2012 ogxi Average Period To Maturity For Portfolio Of Cash And Marketable Securities
AveragePeriodToMaturityForPortfolioOfCashAndMarketableSecurities
P121D
CY2012 ogxi Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
-33000
CY2012 ogxi Income Tax Reconciliation Book To Tax Return Adjustments
IncomeTaxReconciliationBookToTaxReturnAdjustments
287000
CY2012 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
20095000
CY2012 ogxi Income Tax Reconciliation Reduction In Benefit Of Other Tax Attributes
IncomeTaxReconciliationReductionInBenefitOfOtherTaxAttributes
551000
CY2012 ogxi Maximum Maturity Period Of Marketable Securities
MaximumMaturityPeriodOfMarketableSecurities
P1Y
CY2012 ogxi Future Income Tax Rate Assumed For Deferred Tax Calculations
FutureIncomeTaxRateAssumedForDeferredTaxCalculations
0.34 pure
CY2012 ogxi Income Tax Reconciliation Change In Benefit Of Operating Losses
IncomeTaxReconciliationChangeInBenefitOfOperatingLosses
15000
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.46
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-6697000
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
13355000
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2500000
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10855000
CY2013Q1 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
5076000
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.67
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1357000
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-6860000
CY2012Q1 us-gaap Costs And Expenses
CostsAndExpenses
6819000
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1737000
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5082000
CY2012Q1 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
1316000
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1729000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-4215000
CY2012Q2 us-gaap Costs And Expenses
CostsAndExpenses
8373000
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2047000
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6326000
CY2012Q2 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
2429000
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.57
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
976000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-8420000
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
15736000
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2473000
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13263000
CY2013Q2 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
6340000
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.40
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2370000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-5920000
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
14860000
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1965000
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12895000
CY2012Q3 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
6570000
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.68
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
561000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-10054000
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
20477000
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2473000
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18004000
CY2013Q3 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
9862000
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2012Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2147000
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-4103000
CY2012Q4 us-gaap Costs And Expenses
CostsAndExpenses
16030000
CY2012Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2042000
CY2012Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15645000
CY2012Q4 us-gaap Restructuring Costs
RestructuringCosts
-1657000
CY2012Q4 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
9780000
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
CY2013Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
359000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-6678000
CY2013Q4 us-gaap Costs And Expenses
CostsAndExpenses
15641000
CY2013Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2446000
CY2013Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13195000
CY2013Q4 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
8604000

Files In Submission

Name View Source Status
0001193125-14-093757-index-headers.html Edgar Link pending
0001193125-14-093757-index.html Edgar Link pending
0001193125-14-093757.txt Edgar Link pending
0001193125-14-093757-xbrl.zip Edgar Link pending
d650414d10k.htm Edgar Link pending
d650414dex211.htm Edgar Link pending
d650414dex231.htm Edgar Link pending
d650414dex311.htm Edgar Link pending
d650414dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g650414g01g77.jpg Edgar Link pending
g650414g09q99.jpg Edgar Link pending
g650414g47g17.jpg Edgar Link pending
g650414g62h54.jpg Edgar Link pending
g650414g62t32.jpg Edgar Link pending
g650414g70u39.jpg Edgar Link pending
g650414g74a02.jpg Edgar Link pending
g650414g74z34.jpg Edgar Link pending
g650414g83h52.jpg Edgar Link pending
g650414g86q02.jpg Edgar Link pending
g650414g87m41.jpg Edgar Link pending
g650414g99y28.jpg Edgar Link pending
ogxi-20131231.xml Edgar Link completed
ogxi-20131231.xsd Edgar Link pending
ogxi-20131231_cal.xml Edgar Link unprocessable
ogxi-20131231_def.xml Edgar Link unprocessable
ogxi-20131231_lab.xml Edgar Link unprocessable
ogxi-20131231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending